Supreme Court: Promotion Suitability Must be Decided by Experts, Courts Cannot Create New Methods  ||  SC: Market Integrity is Paramount; Rule Violators Cannot Escape Liability by Citing Investor Gains  ||  SC: Plaintiff's Reply to Counterclaim in Commercial Suits Must Meet Written Statement Deadline  ||  SC: Pre-2016 Debt Recovery Tribunal Recovery Certificates Cannot Support Insolvency Notices  ||  SC: Children's Court Cannot Try Child as Adult Without Passing a Reasoned Order under JJ Act  ||  SC: Contractual Clauses Denying Interest on Security Deposits Does Not Violate Public Policy  ||  J&K&L HC: Unamended Pleading Loses Effect After Amendment; Party Cannot Benefit From Own Default  ||  Allahabad HC: Wife's Maintenance Need Not be Fixed at 25% of Husband's Net Income  ||  Kerala HC: Social Customs Alone Cannot Prove Bride Entrusted Gold to Husband or In-Laws  ||  Karnataka HC: Century Club Qualifies as a Public Authority under the RTI Act Due to Land Grant    

Finalization of Draft Rules on Sale of Drugs by E-Pharmacies- (Press Information Bureau) (25 Jun 2019)

MANU/PIBU/0667/2019

Law of Medicine

The Government has published draft rules vide G.S.R. 817 (E) dated 28th August 2018 for inviting public/stakeholder comments for amendment to the Drugs and Cosmetics Rules, 1945 for incorporating provisions relating to regulation of sale and distribution of drugs through e-pharmacy. A large number of suggestions/comments have been received from the stakeholders, which are being examined. At the same time, the matter is sub-judice before various Hon'ble High Courts in the country. Therefore, no timeline for finalization of the rules can be provided.

Under the Drugs & Cosmetics Act and Rules, sale of spurious drugs is a punishable offence and State Licensing Authorities are empowered to take action in this regard. Accordingly, the complaints as received, are referred to State Licensing Authorities for taking action as per the provisions of the Act and Rules.

Tags : DRAFT RULES   FINALIZATION   SALE OF DRUGS   E-PHARMACIES  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved